Skip to main content

Advertisement

ADVERTISEMENT

Peripheral Arterial Disease: Features

Dr Schneider
ISET 2023
01/17/2023

Written by Amanda Wright Harvey

Presented by Peter A. Schneider, MD; Marianne Brodmann, MD; William Gray, MD; Kenneth Rosenfield, MD

Written by Amanda Wright Harvey Pres...
In this session from Tuesday afternoon, Peter A. Schneider, MD, Marianne Brodmann, MD, William Gray, MD, and Kenneth Rosenfield, MD reported 24-month results from the TRANSCEND study, which compared the SurVeil drug-coated balloon (DCB) to...
In this session from Tuesday afternoon, Peter A. Schneider, MD, Marianne Brodmann, MD, William Gray, MD, and Kenneth Rosenfield, MD reported 24-month results from the TRANSCEND study, which compared the SurVeil drug-coated balloon (DCB) to...
In this session from Tuesday...
01/17/2023
Vascular Disease Management
Dr Secemsky
ISET 2023
01/17/2023

Written by Amanda Wright Harvey

Presented by Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Written by Amanda Wright Harvey Pres...
In a Tuesday session at ISET, Dr. Eric Secemsky presented information on intravascular ultrasound imaging, which can significantly improve clinical outcomes in coronary interventions.
In a Tuesday session at ISET, Dr. Eric Secemsky presented information on intravascular ultrasound imaging, which can significantly improve clinical outcomes in coronary interventions.
In a Tuesday session at ISET,...
01/17/2023
Vascular Disease Management
Dr Secemsky
ISET 2023
01/17/2023

Written by Amanda Wright Harvey

Presented by Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM,  Beth Israel Deaconess Medical Center, Boston, Massachusetts

Written by Amanda Wright Harvey Pres...
Vessel preparation creates an optimal environment for primary therapy, such as angioplasty, drug-coated balloons, and stenting, according to Eric Secemsky, MD, Director of Vascular Intervention at Beth Israel Deaconess Medical Center in...
Vessel preparation creates an optimal environment for primary therapy, such as angioplasty, drug-coated balloons, and stenting, according to Eric Secemsky, MD, Director of Vascular Intervention at Beth Israel Deaconess Medical Center in...
Vessel preparation creates an...
01/17/2023
Vascular Disease Management
Dr Aronow
ISET 2023
01/16/2023

Presented by Herbert D. Aronow, MD, MPH, FSVM, FACC, FSCAI, Henry Ford Health, Detroit, Michigan

Presented by Herbert D. Aronow, MD, M...
During a Monday morning session, Dr. Herbert Aronow, president of the Society for Vascular Medicine, discussed long-term goals following endovascular therapy for PAD.
During a Monday morning session, Dr. Herbert Aronow, president of the Society for Vascular Medicine, discussed long-term goals following endovascular therapy for PAD.
During a Monday morning session,...
01/16/2023
Vascular Disease Management
Dr Simons
ISET 2023
01/16/2023

Presented by Jessica P. Simons, MD, MPH, DFSVS, UMass Chan Medical School, Worcester, Massachusetts

Presented by Jessica P. Simons, MD, M...
During Monday morning’s session on Essentials of Endovascular Therapy, Dr. Jessica P. Simons of UMass Chan Medical School presented information on evaluating and managing intermittent claudication and chronic limb-threatening ischemia (CLTI).
During Monday morning’s session on Essentials of Endovascular Therapy, Dr. Jessica P. Simons of UMass Chan Medical School presented information on evaluating and managing intermittent claudication and chronic limb-threatening ischemia (CLTI).
During Monday morning’s session...
01/16/2023
Vascular Disease Management
Editor's Corner
12/15/2022

Craig Walker, MD, FACC, FACP

 

 

Cardiovascular Institute of the South, Houma, Louisiana

Craig Walker, MD, FACC, FACP     C...
Dr. Walker continues his discussion of the BEST-CLI randomized control trial comparing surgery-first with or without an adequate venous conduit vs endovascular-first treatment in patients with CLTI.
Dr. Walker continues his discussion of the BEST-CLI randomized control trial comparing surgery-first with or without an adequate venous conduit vs endovascular-first treatment in patients with CLTI.
Dr. Walker continues his...
12/15/2022
Vascular Disease Management
Video
12/14/2022

Matthew Finn, MD, MSc, and Craig Walker, MD

 

Cardiovascular Institute of the South, Houma, Louisiana

Matthew Finn, MD, MSc, and Craig Walk...
Watch Dr. Matthew Finn continue his discussion on the BEST-CLI randomized trial.
Watch Dr. Matthew Finn continue his discussion on the BEST-CLI randomized trial.
Watch Dr. Matthew Finn continue...
12/14/2022
Vascular Disease Management
Original Research
12/14/2022

Nicholas Morrissey, MD1; B. Timothy Baxter, MD2; Michael Belkin, MD3; William T. Bohannon, MD, FACS4; Jose Borromeo, MD, FACS5; Nitin Garg, MBBS, MPH6; Larry Kraiss, MD7; Nicholas Osborne, MD8; Todd Russell, MD, FACS9; Wei Zhou, MD10

 

 

 

1Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, Division of Vascular Surgery and Endovascular Interventions, New York, New York; 2University of Nebraska Medical Center, Omaha, Nebraska; 3Brigham & Women's Hospital, Boston, Massachusetts; 4Baylor Scott & White, Temple, Texas; 5Iowa Heart Center, West Des Moines, Iowa; 6Peak Heart and Vascular, Avondale, Arizona; 7University of Utah School of Medicine, Salt Lake City, Utah; 8University of Michigan, Ann Arbor, Michigan; 9Jobst Vascular Institute, Toledo, Ohio; 10University of Arizona, Tucson, Arizona

Nicholas Morrissey, MD1; B. Timothy B...
This article reports the results from the first clinical study of a BPP processed through photo-oxidation, without the use of glutaraldehyde, in procedures for CAS, as well as PAD.
This article reports the results from the first clinical study of a BPP processed through photo-oxidation, without the use of glutaraldehyde, in procedures for CAS, as well as PAD.
This article reports the results...
12/14/2022
Vascular Disease Management
Editor's Corner
11/16/2022

Matthew Finn, MD, MSc, and Craig Walker, MD

Cardiovascular Institute of the South, Houma, Louisiana

Matthew Finn, MD, MSc, and Craig Walk...
Drs. Finn and Walker discuss the results of the long-awaited BEST-CLI randomized control trial, which was presented at the American Heart Association’s 2022 Scientific Sessions in November.
Drs. Finn and Walker discuss the results of the long-awaited BEST-CLI randomized control trial, which was presented at the American Heart Association’s 2022 Scientific Sessions in November.
Drs. Finn and Walker discuss the...
11/16/2022
Vascular Disease Management
Video
11/16/2022

Matthew Finn, MD, MSc, and Craig Walker, MD
 

Cardiovascular Institute of the South, Houma, Louisiana

Matthew Finn, MD, MSc, and Craig Walk...
Dr. Matthew Finn discusses the results of the just-released BEST-CLI trial.
Dr. Matthew Finn discusses the results of the just-released BEST-CLI trial.
Dr. Matthew Finn discusses the...
11/16/2022
Vascular Disease Management

Advertisement

Advertisement

Advertisement